Ignite Creation Date:
2024-05-06 @ 8:02 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06229145
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-01-19
Brief Title:
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks Q4W With MTX Compared With Every 2 Weeks Q2W With MTX in Participants With Uncontrolled Refractory Gout
Sponsor:
Amgen
Organization:
Amgen
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-19
First Submit QC Date:
January 19 2024
Study First Post Date:
2024-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-17
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL